Shay Capital’s OptiNose OPTN Stock Holding History

Shay Capital’s Portfolio OPTN Stock Details OPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,516	Closed	-$42.1K	–	503
2022 Q4	$42.1K	Buy	+1,516	New	+$57.6K	0.01%	232

Other funds holding OPTN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Shay Capital's OPTN Position: Q1 2023 in Review

Shay Capital sold out of OptiNose (OPTN) in Q1 2023, closing a stake of 1,516 shares — an estimated $42.1K sold.

Shay Capital first reported a position in OPTN in Q4 2022 and held it in 1 quarter. The position peaked at $42.1K in Q4 2022. 62 funds tracked by Wall St. Rank hold OPTN as of Q1 2023.

Shay Capital reported no remaining OptiNose position as of Q1 2023 after selling out during the quarter.
Shay Capital sold 1,516 OptiNose shares in Q1 2023, an estimated $42.1K.
Shay Capital first reported a position in OptiNose in Q4 2022 and held it in 1 quarter.
Shay Capital's OptiNose position peaked at $42.1K in Q4 2022.
62 funds tracked by Wall St. Rank held OptiNose as of Q1 2023.

Based on Shay Capital's 13F filing for Q1 2023, filed 15 May 2023.